全文获取类型
收费全文 | 18369篇 |
免费 | 1532篇 |
国内免费 | 554篇 |
学科分类
医药卫生 | 20455篇 |
出版年
2024年 | 33篇 |
2023年 | 268篇 |
2022年 | 388篇 |
2021年 | 606篇 |
2020年 | 618篇 |
2019年 | 577篇 |
2018年 | 535篇 |
2017年 | 603篇 |
2016年 | 578篇 |
2015年 | 721篇 |
2014年 | 1123篇 |
2013年 | 1183篇 |
2012年 | 890篇 |
2011年 | 1094篇 |
2010年 | 776篇 |
2009年 | 788篇 |
2008年 | 778篇 |
2007年 | 741篇 |
2006年 | 704篇 |
2005年 | 675篇 |
2004年 | 672篇 |
2003年 | 497篇 |
2002年 | 444篇 |
2001年 | 441篇 |
2000年 | 327篇 |
1999年 | 319篇 |
1998年 | 313篇 |
1997年 | 235篇 |
1996年 | 313篇 |
1995年 | 317篇 |
1994年 | 290篇 |
1993年 | 261篇 |
1992年 | 248篇 |
1991年 | 224篇 |
1990年 | 175篇 |
1989年 | 187篇 |
1988年 | 183篇 |
1987年 | 135篇 |
1986年 | 114篇 |
1985年 | 215篇 |
1984年 | 167篇 |
1983年 | 106篇 |
1982年 | 133篇 |
1981年 | 104篇 |
1980年 | 83篇 |
1979年 | 91篇 |
1978年 | 61篇 |
1977年 | 48篇 |
1976年 | 46篇 |
1975年 | 13篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
51.
Azra Raza Harvey D. Preisler Ya Qin Li Richard A. Larson Jack Goldberg George Browman John Bennett Hans Grunwald Ralph Vogler Cathi Kukla 《American journal of hematology》1993,42(4):359-366
A pilot study was conducted of the biological characteristics of the leukemia cells of newly diagnosed patients with poor prognosis acute myelogenous leukemia (AML). This study included measurements of the pretherapy proliferative rate of the leukemia cells in vivo, assessment of differentiation in vivo during remission induction therapy, and the level of expression of the fms, myc, and IL1β genes in pretherapy leukemia cells. Short cell cycle times were characteristic of the best prognostic category and were associated with a rapid reduction in marrow leukemia cells in cytosine arabinoside (araC)-sensitive patients. Expression of c-fms was associated with rapid reduction in marrow leukemia cells during araC therapy and with a successful treatment outcome. Expression of the IL1β gene was associated with short remissions. These studies suggest that when compared to newly diagnosed standard prognosis AML, the leukemia of poor prognosis patients is more likely to exhibit long cell cycle times, low levels of fms expression, and is less likely to be associated with myeloid differentiation during remission induction therapy. © 1993 Wiley-Liss, Inc. 相似文献
52.
进一步研究了抗三尖杉酯碱的HL-60细胞(HR20)抗细胞凋亡的机制及该抗性和抗药性的关系。结果表明,环孢菌素A(CsA)20,10μg·ml ̄(-1)诱导HL-60细胞发生凋亡,而阻断HR20细胞于G_1期,就不能诱导细胞发生凋亡。低浓度的CsA明显增加柔红霉素在HR20细胞内的积聚,其逆转抗药性作用与阻断细胞周期运行无关。CsA10μg·ml ̄(-1)处理HR20细胞,可引起50kDa的蛋白质高度磷酸化。结果提示:环孢菌素A阻断抗三尖杉酯碱的HL-60细胞于G_1期,而诱导敏感的HL-60细胞发生凋亡,其阻断作用与抗药性无关 相似文献
53.
M. Brugiatelli B. Jaksic A. Planinc-Peraica R. Kusec S. Ostojic V. Callea P. Lacopino F. Morabito C. Stelitano D. Lutz 《European journal of haematology》1995,55(3):158-163
Abstract: In 1982 the IGCI CLL cooperative group decided to investigate the usefulness of treating, at diagnosis B-cell chronic lymphocytic leukemia (CLL) in early and stable phase of the disease. From January 1982 to December 1986, 148 patients were randomized either to receive immediate treatment with chlorambucil (CLB) or to defer therapy to the time of progression. The early and stable phase of the disease was defined by a total tumor mass (TTM) score < 9, the absence of anemia or thrombocytopenia and a doubling time > 12 months. The main end-point of the study was survival. At the last evaluation in April 1993, after a median follow-up of 75 months, no significant difference was found in overall survival between early vs. deferred treatment patients from every cause of death as well as from death due to CLL-related causes only. The same results were obtained when the patients in more favorable stages, such as Binet stage A and TTM < 4.5, were considered. Interestingly, the incidence of epithelial cancer was similar in the two groups. Early treatment was associated with a significantly better response and a lower progression rate. From this long-term experience, it can be concluded that immediate chemotherapy with CLB is not beneficial for CLL patients in early and stable phase of the disease in terms of survival. 相似文献
54.
Wing-Yen Wong Donald Williams Marilyn L. Slovak Bishan Charak Amitabha Mazumder David Snyder Darleen R. Powars Russell K. Brynes 《American journal of hematology》1993,43(2):133-138
Congenital agranulocytosis terminating in acute myelogenous leukemia has been previously reported in only two cases of adolescent males. We describe the clinical and laboratory features of a 13-year-old male with congenital agranulocytosis, treated with G-CSF with initial good neutrophil response, who subsequently developed acute myeloid leukemia. This rare complication may define a preleukemic subset of patients for whom G-CSF therapy is ineffective. The diagnostic challenges of this case are presented. 相似文献
55.
单用全反式维甲酸(RA)诱导治疗急性早幼粒细胞白血病(APL)20例,完全缓解率达90%,诱导天数短(中位数为32d)。治疗过程中未发生DIC,亦无因强烈化疗引起骨髓抑制后造成的感染和出血的危险。该药的副反应轻,患者均能耐受。该组的中位生存期已达630d,可望长期存活。 相似文献
56.
Suzuki Hisamitsu; Ota Kazuo; Ohno Ryuzo; Masaoka Toru; Shibata Hirotoshi; Kimura Ikuro; Amaki Ichita; Miura Yasusada; Uzuka Yoshiro; Kawato Masafumi; Shirakawa Shigeru; Hirota Yutaka; Maekawa Tadashi; lmai Kuniyuki; Takaku Fumimaro; Shimoyama Masanori; Kitahara Takeshi; Oguro Masao; Kozuru Mitsuo; Kawagoe Hiroya; Nakamura Toru; Yamada Kazumasa 《Japanese journal of clinical oncology》1989,19(4):338-347
Patients with acute (2,569) and chronic (957) leukemia diagnosedat 19 institutes took part in the study on the "MultidisciplinaryTreatment of Leukemia" between 1971 and 1985 and were investigatedretrospectively. By dividing the 15 years into three five-yearperiods, we were able to compare patient ratios in the differentperiods. The proportions of acute to chronic leukemia casesshowed no obvious change; however, the proportions of casesdiagnosed as acute lymphocytic leukemia in acute leukemia showeda significant increase. The main chemotherapeutic drugs usedduring the three time periods were cytarabine or its analogues,the anthracyclines, 6-mercaputopurine and prednisolone, againstacute myelogenous leukemia, and the vinca alkaloids, prednisoloneand the anthracyclines against acute lymphocytic leukemia. Therate of complete remission from acute myelogenous leukemia mademarked progress, from 45.1% during 19711975 to 62.3%during 19811985, but that of acute lymphocytic leukemiashowed no significant progress, being 65% during 19711975and 69.7% during 19811985. The durations of remission,however, and the survival times for patients with acute lymphocyticleukemia, as well as for those with acute myelogenous leukemia,became significantly longer over the three periods. Median survivaltimes from chronic myelocytic leukemia were 3740 mo inall three periods, showing no progress. There was a better prognosisin cases of chronic myelocytic leukemia with, than without,Philadelphia chromosome. Except for a low incidence of chroniclymphocytic leukemia in Japan, adult leukemia patients' characteristicsand prognoses seem to be almost the same in Japan as in theU.S.A. and Europe. 相似文献
57.
Monoclonal antibodies against human granulocytes and myeloid differentiation antigens 总被引:4,自引:0,他引:4
Patrice Mannoni Anna Janowska-Wieczorek A. Robert Turner Locksley McGann Jean-Michael Turc 《Human immunology》1982,5(4):309-323
Monoclonal antibodies (MCA) were obtained by immunizing BALB/c mice with 99% pure granulocytes from normal donors or with a whole leukocyte suspension obtained from a chronic myelogenous leukemia (CML) patient, and then fusing the mouse spleen cells with a 315–43 myeloma cell clone. Four MCA were selected and studied using ELISA, immunofluorescence, cytotoxicity assays, and FACS analysis. Antibodies 80H.1. 80H.3. and 80H.5 (from normals) and 81H.1 (from CML) detected antigens expressed on neutrophils. Antibodies 80H.1 and 80H.3 (lgG) also reacted with monocytes but not with other blood cell subsets. Antibodies 80H.5 and 81H.1 (lgM) were cytotoxic and reacted strongly with most of the cells of the neutrophil maturation sequence. i.e., myeloblasts, promyelocytes, myelocytes, and mature granulocytes. Antibodies 80H.5 and 81H.1 also inhibited BFU-GM and CFU-E. Antigens recognized by 80H.3. 80H.5, and 81H.1 were expressed both on a proportion of cells from HL.60, KG.1, ML.1, and K562 myeloid cell lines, and on a proportion of blast cells isolated from patients with acute myelogenous leukemia. They were not found on lymphoid cell lines or lymphoid leukemia cells. These MCA recognize either late differentiation antigens expressed on mature neutrophils and monocytes (80H.1 and 80H.3) or early differentiation antigens (80H.5 and 81H.1) specific to the granulocytic lineage. They may be useful for a better definition of those antigens specific to hematopoietic stem cells and their relationship with normal or neoplastic hematopoiesis. 相似文献
58.
Akihiro Umezawa Taketo Yamada Yuuto Ogawa Shigeru Kuramochi Yonosuke Watanabe 《Pathology international》1990,40(9):693-698
An autopsy case of acute megakaryocytic leukemia (AMKL) is presented. The bone marrow was hypercellular with proliferation of three lineages, especially megakaryocytes. Immunohistochemical examination revealed many platelet glycoprotein IIb/IIIa (GP IIb/IIIa)- positive blast cells in bone marrow. The proportion of the blasts was 26.4% by tissue hemogram. GP IIb/IIIa-positive blasts and megakaryoblasts were deposited massively in lymph nodes. lmmunohistochemistry against GP IIb/IIIa and tissue hemograms by paraffin section are needed to diagnose AMKL by postmortem examination, since the identification of ultra-structural platelet peroxidase in autopsy materials is difficult. 相似文献
59.
彭代雄 《中国优生与遗传杂志》2006,14(6):18-19
目的探讨慢性粒细胞性白血病(ehron ic myeloid leukem ia CML)ber/ab l融合基因检测及意义。方法采用荧光定量PCR(FQ-PCR)检测56例慢性粒细胞性白血病中ber/ab l融合基因的表达。结果对照组bcr/ab l基因表达均为阴性。56例慢性粒细胞性白血病病人bcr/ab l基因表达阳性率为87.5%(49/56),表达值范围3.0×107-7.9×107基因拷贝/L;33例CML患者Ph染色体分析结果中25例为Ph( )/bcr(十),2例为Ph(-)/bcr( ),4例Ph( )/bcr(-),1例Ph(-)/bcr(-);8例CML患者治疗前ber/ab l基因表达均值为(2.60±0.9)×107基因拷贝/L,治疗后为(1.78±0.6)×107基因拷贝/L,两者具有显著性差异(P<0.05=。结论bcr/ab l融合基因表达水平的定量检测及动态观察,对CML的临床诊断、疗效观察和预后具有重要意义。 相似文献
60.
急性白血病的基因表达谱分析与亚型分类特征的鉴别 总被引:7,自引:0,他引:7
本研究基于生物信息学理论,运用模式识别方法和计算技术,对急性白血病的基因表达谱数据进行分析,研究急性白血病的亚型识别与分类信息基因选取问题。首先去除无关基因,然后利用浮动顺序搜索算法搜索特征空间生成候选特征子集,最后以支持向量机作为分类器进行急性白血病的亚型识别,并以误识率为依据鉴别出了5个包含完整分类信息的基因。实验结果表明,本研究鉴别出的5个信息基因能以100%的正确率准确识别急性白血病亚型。 相似文献